185 related articles for article (PubMed ID: 1544223)
21. In vivo modulation of atypical mycobacterial infection: adjuvant therapy increases resistance to Mycobacterium avium by enhancing macrophage effector functions.
Denis M
Cell Immunol; 1991 Apr; 134(1):42-53. PubMed ID: 2013106
[TBL] [Abstract][Full Text] [Related]
22. Cytokine-mediated activation of macrophages from Mycobacterium bovis BCG-resistant and -susceptible mice: differential effects of corticosterone on antimycobacterial activity and expression of the Bcg gene (Candidate Nramp).
Brown DH; LaFuse W; Zwilling BS
Infect Immun; 1995 Aug; 63(8):2983-8. PubMed ID: 7622220
[TBL] [Abstract][Full Text] [Related]
23. Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection.
Xu DL; Goto Y; Amoako KK; Nagatomo T; Uchida K; Shinjo T
Clin Exp Immunol; 1995 Dec; 102(3):523-8. PubMed ID: 8536367
[TBL] [Abstract][Full Text] [Related]
24. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection.
Appelberg R; Castro AG; Pedrosa J; Silva RA; Orme IM; Minóprio P
Infect Immun; 1994 Sep; 62(9):3962-71. PubMed ID: 8063414
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal control of Mycobacterium avium and Mycobacterium tuberculosis infections by the alleles of the classic Class II H2-Aβ gene in mice.
Linge I; Petrova E; Dyatlov A; Kondratieva T; Logunova N; Majorov K; Kondratieva E; Apt A
Infect Genet Evol; 2019 Oct; 74():103933. PubMed ID: 31229664
[TBL] [Abstract][Full Text] [Related]
26. Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium.
Eriks IS; Emerson CL
Infect Immun; 1997 Jun; 65(6):2100-6. PubMed ID: 9169738
[TBL] [Abstract][Full Text] [Related]
27. Virulence of Mycobacterium avium in mice does not correlate with resistance to nitric oxide.
Lousada S; Flórido M; Appelberg R
Microb Pathog; 2007; 43(5-6):243-8. PubMed ID: 17683898
[TBL] [Abstract][Full Text] [Related]
28. Role of gamma delta T cells in immunopathology of pulmonary Mycobacterium avium infection in mice.
Saunders BM; Frank AA; Cooper AM; Orme IM
Infect Immun; 1998 Nov; 66(11):5508-14. PubMed ID: 9784564
[TBL] [Abstract][Full Text] [Related]
29. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice.
Castro AG; Silva RA; Appelberg R
J Immunol; 1995 Aug; 155(4):2013-9. PubMed ID: 7636252
[TBL] [Abstract][Full Text] [Related]
30. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice.
Appelberg R; Castro AG; Pedrosa J; Minóprio P
Immunology; 1994 Jul; 82(3):361-4. PubMed ID: 7959868
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice.
Pedrosa J; Flórido M; Kunze ZM; Castro AG; Portaels F; McFadden J; Silva MT; Appelberg R
Clin Exp Immunol; 1994 Nov; 98(2):210-6. PubMed ID: 7955524
[TBL] [Abstract][Full Text] [Related]
32. The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium avium.
Borges M; Rosa GT; Appelberg R
Clin Exp Immunol; 2011 Jun; 164(3):407-16. PubMed ID: 21470210
[TBL] [Abstract][Full Text] [Related]
33. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
Kramnik I; Radzioch D; Skamene E
Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria.
Denis M
Clin Exp Immunol; 1991 Mar; 83(3):466-71. PubMed ID: 1900745
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?
Appelberg R
Immunol Res; 2006; 35(3):179-90. PubMed ID: 17172645
[TBL] [Abstract][Full Text] [Related]
36. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
Flórido M; Borges M; Yagita H; Appelberg R
J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages.
Crowle AJ; Tsang AY; Vatter AE; May MH
J Clin Microbiol; 1986 Nov; 24(5):812-21. PubMed ID: 3771767
[TBL] [Abstract][Full Text] [Related]
38. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene.
Gomes MS; Flórido M; Pais TF; Appelberg R
J Immunol; 1999 Jun; 162(11):6734-9. PubMed ID: 10352292
[TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinases p38 and ERK1/2 regulated control of Mycobacterium avium replication in primary murine macrophages is independent of tumor necrosis factor-α and interleukin-10.
Klug K; Ehlers S; Uhlig S; Reiling N
Innate Immun; 2011 Oct; 17(5):470-85. PubMed ID: 20682586
[TBL] [Abstract][Full Text] [Related]
40. Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway.
Halaas O; Steigedal M; Haug M; Awuh JA; Ryan L; Brech A; Sato S; Husebye H; Cangelosi GA; Akira S; Strong RK; Espevik T; Flo TH
J Infect Dis; 2010 Mar; 201(5):783-92. PubMed ID: 20121435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
